Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of tolterodine versus oxybutynin in treatment of nocturnal enuresis
IRCT20141224020419N3Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tolterodine and oxybutynin in nocturnal enuresis (NE) (2 arms), sponsored by Mazandaran University of Medical Sciences. Started Nov 2018; status: completed.
02
Drugs
tolterodineoxybutynin
03
Conditions
nocturnal enuresis (NE)
Beyond the preview
Go deeper on IRCT20141224020419N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141224020419N3.